0001062993-23-022658.txt : 20231215 0001062993-23-022658.hdr.sgml : 20231215 20231215173322 ACCESSION NUMBER: 0001062993-23-022658 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231214 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beattie John Gregory CENTRAL INDEX KEY: 0001845679 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 231491523 MAIL ADDRESS: STREET 1: C/O BIOANALYTICAL SYSTEMS, INC. STREET 2: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inotiv, Inc. CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 FORMER COMPANY: FORMER CONFORMED NAME: BIOANALYTICAL SYSTEMS INC DATE OF NAME CHANGE: 19970918 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-14 0000720154 Inotiv, Inc. NOTV 0001845679 Beattie John Gregory 2701 KENT AVENUE WEST LAFAYETTE IN 47906-1382 0 1 0 0 Chief Operating Officer 0 Common Stock 2023-12-14 4 P 0 47966 3.1238 A 111761 D Employee Stock Option (right to buy) 3.0895 2023-12-15 4 A 0 7500 0 A 2033-12-15 Common Stock 7500 7500 D Reflects the weighted average price of 47,966 common shares purchased by the reporting person in multiple transactions on December 14, 2023 with purchase prices ranging from $2.88 to 3.30 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Represents a grant of non-qualified options, which have a three year vesting period of 40% / 30% / 30% beginning on the first anniversary of the grant date, subject to continued employment. /s/ Beth Taylor, attorney-in-fact for John Gregory Beattie 2023-12-15